David L. Scott

Active 1981–2024

Also published as
David L Scott
98
Papers
24,151
Citations
79
h-index
98
i10-index

Citations

Citations per year for David L. Scott1916: 1 citations1961: 1 citations1981: 1 citations1982: 1 citations1983: 2 citations1984: 3 citations1985: 13 citations1986: 12 citations1987: 13 citations1988: 16 citations1989: 13 citations1990: 27 citations1991: 27 citations1992: 41 citations1993: 27 citations1994: 40 citations1995: 61 citations1996: 37 citations1997: 52 citations1998: 54 citations1999: 60 citations2000: 95 citations2001: 115 citations2002: 170 citations2003: 184 citations2004: 187 citations2005: 156 citations2006: 154 citations2007: 164 citations2008: 140 citations2009: 164 citations2010: 130 citations2011: 173 citations2012: 164 citations2013: 166 citations2014: 155 citations2015: 198 citations2016: 164 citations2017: 157 citations2018: 112 citations2019: 515 citations2020: 502 citations2021: 421 citations2022: 334 citations2023: 191 citations2024: 299 citations2025: 119 citations2026: 1 citations1917–1960: no citations, so these years are not shown1962–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,892 citing papers, 21.9% of this breakdownUnited Kingdom: 898 citing papers, 10.4% of this breakdownChina: 627 citing papers, 7.3% of this breakdownGermany: 435 citing papers, 5% of this breakdownNetherlands: 434 citing papers, 5% of this breakdownCanada: 354 citing papers, 4.1% of this breakdownFrance: 319 citing papers, 3.7% of this breakdownItaly: 315 citing papers, 3.7% of this breakdownJapan: 269 citing papers, 3.1% of this breakdownSpain: 215 citing papers, 2.5% of this breakdownSweden: 202 citing papers, 2.3% of this breakdownAustralia: 194 citing papers, 2.2% of this breakdown
0%21.9%Other 28.8%

Fields

  • Medicine67.1%
  • Biochemistry, Genetics and Molecular Biology19.2%
  • Immunology and Microbiology4.3%
  • Neuroscience2.7%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Agricultural and Biological Sciences0.9%
  • Other4.8%

Topics

  • Rheumatoid Arthritis Research and Therapies13.7%
  • Spondyloarthritis Studies and Treatments4.3%
  • Autoimmune and Inflammatory Disorders Research3.8%
  • Systemic Lupus Erythematosus Research3.4%
  • Cell Adhesion Molecules Research2.5%
  • Monoclonal and Polyclonal Antibodies Research1.5%
  • Other70.8%

Coauthors

All papers

Open in search
  1. Rheumatoid arthritis

    Authors: , , - The Lancet 2010 cited by 3,012

  2. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis

    Authors: , , , , , , , - Seminars in Arthritis and Rheumatism 2014 cited by 517

  3. Crystal Structure of the Extracellular Segment of Integrin αVβ3

    Authors: , , , , , , , , - Science 2001 cited by 1,275

  4. Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Parke, Anthony Rowe, Arnaud Didierlaurent, Ashley Gilmour, Athula Herath, Ayako Wakatsuki, Pedersen Aysin, Tulunay Virlan, Ben Allen, Benjamin A Fisher, Blerina Kola, Bohdan Harvey, Brian Tom, Carl S Goodyear, Carolyn Cuff, Catharien Hilkens, Catharina Lindholm, Catherine T Mela, Christopher D Buckley, Chris Larminie, Chris Marshall, Christopher John, Christopher M Mela, Claudio Carini, Costantino Pitzalis, Coziana Ciurtin, Dan Baker, Daniel Ziemek, Daniela Dastros-Pitei, Dao Nguyen, David L Scott, David S Watson, Deborah Symmons, Dennis Lendrem, Denny Verbeeck, Desmond Padhji, Donna Finch, Duncan Porter, Emma Vernon, Faye Cooles, Feng Hong, Fiona Clarke, Fiona Stirling, Fowzia Ibrahim, Frances Humby, Francisco Bonachela Capdevila, Frederic Geissmann, Frederique Ponchel, Gemma Molyneux, Gemma Simpson, Georgina Thorborn, Gerry Parker, Gioia Altobelli, Graham R Smith, Hannah Edwards, Hannah Tipney, Hans-Dieter Zucht, Hayley Noble, Heidi Lempp, Humayara AliIain B McInnes, Ian C Scott, Ian N BruceIona Donnelly, Ivana Vranic, James A Butler, James Galloway, Jamie C Sergeant, Jane Worthington, Jehan El-Jawhari, Jessica Tarn, Joanne Ellis and 70 more - Annals of the Rheumatic Diseases 2022 cited by 60

  5. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial

    Authors: , , , , - Lara D. Veeken 2015 cited by 226

  6. Fatigue in rheumatoid arthritis reflects pain, not disease activity

    Authors: , , , , - Lara D. Veeken 2006 cited by 453

  7. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease

    Authors: , , , , , , , , , , , , , - Lara D. Veeken 2003 cited by 367

  8. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel E. Mulholland, Sarah Pett, Ian Galea, Rhys H. Thomas, Laura Benjamin, Ming Lim, Yael Hacohen, Tom Solomon, Mike Griffiths, Benedict Michael, Rachel Kneen, Gerome Breen, Hannah Castell, Ceryce Collie, Lilly George, Monika Hartmann, Marc Henrion, Maria Kinali, Christina Petropoulos, Sithara Ramdas, Victoria Vlachou, Brigitte Vollmer, Bethany Facer, Cordelia Dunai, Laura Benjamin - The Lancet Child & Adolescent Health 2021 cited by 156

  9. Pain Reduction With Oral Methotrexate in Knee Osteoarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2024 cited by 34

  10. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

    Authors: , , , , , , - Arthritis Research & Therapy 2014 cited by 104

  11. Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2018 cited by 91

  12. Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tarnya Marshall, Catherine Mathews, Frank McKenna, Sophia Naz, Mark Perry, Louise Pollard, Brian Quilty, Lindsay Robertson, Dipak Roy, Paul W. Sanders, V. Saravanan, David L. Scott, Gillian Smith, Richard Smith, Deborah Symmons, Lee‐Suan Teh, Nick Viner, Suzanne Verstappen - Lara D. Veeken 2022 cited by 33

  13. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tuulikki Sokka‐Isler, John B. Wong, Désirée van der Heijde - Annals of the Rheumatic Diseases 2013 cited by 1,762

  14. Interfacial Catalysis: the Mechanism of Phospholipase A 2

    Authors: , , , , , - Science 1990 cited by 703

  15. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

    Authors: , , , , , , , , , , , , - Lara D. Veeken 2012 cited by 322

  16. Intestinal permeability and inflammation in patients on NSAIDs

    Authors: , , , , , , , , - Gut 1998 cited by 191

  17. RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carl S. Goodyear, Iain B. McInnes, Iona Donnelly, Ashley Gilmour, Aysın Tulunay Virlan, Duncan Porter, Frédérique Ponchel, Paul Emery, Jehan J. El‐Jawhari, Rekha Parmar, Michael McDermott, Benjamin A. Fisher, Steve Young, Philip Jones, Karim Raza, Andrew Filer, Costantino Pitzalis, Michael R. Barnes, David Watson, Rafael Henkin, Georgina Thorborn, Liliane Fossati‐Jimack, Stephen Kelly, Frances Humby, Michele Bombardieri, Sharmila Rana, Zhilong Jia, Katriona Goldmann, Myles Lewis, Sandra Ng, Adriano Barbosa-Silva, Evan Tzanis, Amaya Gallagher-Syed, Christopher R. John, Michael R. Ehrenstein, Gioia Altobelli, Sandra Martins, Dao X. Nguyen, Humayara Ali, Coziana Ciurtin, Maya H Buch, Deborah Symmons, Jane Worthington, Ian N Bruce, Jamie C. Sergeant, Suzanne Verstappen, F. Stirling, Adwoa Hughes-Morley, Brian D. M. Tom, Vernon T. Farewell, Yujie Zhong, Peter C. Taylor, Christopher D. Buckley, Sarah Keidel, Carolyn A. Cuff, Marc C. Levesque, Andrew J. Long, Zheng Liu, Samantha Lipsky, Bohdan P. Harvey, Michael Macoritto, Feng Hong, Şükrü Kaymakçalan, Wayne Tsuji, Tony Sabin, Neil Ward, Susan Talbot, Desmond Padhji, Matthew A. Sleeman, Donna K. Finch and 52 more - Scientific Data 2022 cited by 25

  18. Integration of cytogenetic landmarks into the draft sequence of the human genome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael P. Morley, Sandya Narasimhan, Kazutoyo Osoegawa, Ze Peng, Ingrid Plajzer-Frick, Bradley J. Quade, David L. Scott, Karl Sirotkin, A. Thorpe, Joe W. Gray, James R. Hudson, Daniel Pinkel, T. Ried, L. Rowen, Grace Shen-Ong, R L Strausberg, Ewan Birney, David F. Callen, Jan‐Fang Cheng, David R. Cox, N. A. Doggett, N. P. Carter, E. E. Eichler, David Haussler, Julie R. Korenberg, Cynthia C. Morton, Donna G. Albertson, G. Schuler, Pieter J. de Jong, Barbara J. Trask - Nature 2001 cited by 324

  19. High prevalence of NSAID enteropathy as shown by a simple faecal test

    Authors: , , , , , , - Gut 1999 cited by 314

  20. Crystal Structure of Bee-Venom Phospholipase A 2 in a Complex with a Transition-State Analogue

    Authors: , , , - Science 1990 cited by 447

  21. Structures of Free and Inhibited Human Secretory Phospholipase A 2 from Inflammatory Exudate

    Authors: , , , , , - Science 1991 cited by 252

  22. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation

    Authors: , , , , , , , , , , , - Health Technology Assessment 2016 cited by 164

  23. Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

    Authors: , , , , , , , , , - BMC Rheumatology 2019 cited by 38

  24. LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS

    Authors: , , , - The Lancet 1987 cited by 597